{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:14:26Z","timestamp":1784970866039,"version":"3.55.0"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Dravet syndrome (DS) is a refractory developmental and epileptic encephalopathy (EE) with a variety of comorbidities, including cognitive impairment, autism-like behavior, speech dysfunction, and ataxia, which can seriously affect the quality of life of patients and impose a great burden on society and their families. Currently, the pharmacological therapy is patient dependent and may work or not. Neuromodulation techniques, including vagus nerve stimulation (VNS), deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), responsive neurostimulation (RNS), and chronic subthreshold cortical stimulation (CSCS), have become common adjuvant therapies for neurological diseases, but their efficacy in the treatment of DS is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched Web of Science, PubMed, and SpringerLink for all published cases related to the neuromodulation techniques of DS until January 15, 2022. The systematic review was supplemented with relevant articles from the references. The results reported by each study were summarized narratively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The Web of science, PubMed and SpringerLink search yielded 258 items. A total of 16 studies published between 2016 and 2021 met the final inclusion criteria. Overall, 16 articles (109 cases) were included in this study, among which fifteen (107 patients) were involved VNS, and one (2 patients) was involved DBS. After VNS implantation, seizures were reduced to \u226550% in 60 cases (56%), seizure free were found in 8 cases (7.5%). Only two DS patients received DBS treatment, and the initial outcomes of DBS implantation were unsatisfactory. The seizures significantly improved over time for both DBS patients after the addition of antiepileptic drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>More than half of the DS patients benefited from VNS, and VNS may be effective in the treatment of DS. However, it is important to note that VNS does not guarantee improvement of seizures, and there is a risk of infection and subsequent device failure. Although DBS is a safe and effective strategy for the treatment of refractory epilepsy, the role of DBS in DS needs further study, as the sample size was small. Thus far, there is no strong evidence for the role of DBS in DS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.843975","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T14:18:05Z","timestamp":1649859485000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Up to What Extent Does Dravet Syndrome Benefit From Neurostimulation Techniques?"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiangwei","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shucai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ilae commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia."},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1528-1167.2011.02997.x","article-title":"The genetics of Dravet syndrome","volume":"52","author":"Marini","year":"2011","journal-title":"Epilepsia."},{"key":"B3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/jmg.2008.062323","article-title":"Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients","volume":"46","author":"Depienne","year":"2009","journal-title":"J Med Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1111\/epi.13889","article-title":"Dravet syndrome and its mimics: beyond SCN1A","volume":"58","author":"Steel","year":"2017","journal-title":"Epilepsia."},{"key":"B5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/17460441.2021.1857722","article-title":"Advances in the design and discovery of novel small molecule drugs for the treatment of Dravet Syndrome","volume":"16","author":"Miziak","year":"2021","journal-title":"Expert Opin Drug Discov."},{"key":"B6","doi-asserted-by":"publisher","first-page":"108024","DOI":"10.1016\/j.yebeh.2021.108024","article-title":"Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: analysis from a phase 3 long-term extension study in children\/young adults with Dravet syndrome","volume":"121","author":"Bishop","year":"2021","journal-title":"Epilepsy Behav."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1017\/cjn.2016.243","article-title":"Dravet syndrome: diagnosis and long-term course","volume":"43","author":"Connolly","year":"2016","journal-title":"Can J Neurol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/B978-0-444-52891-9.00065-8","article-title":"Dravet syndrome (severe myoclonic epilepsy in infancy)","volume":"111","author":"Dravet","year":"2013","journal-title":"Handb Clin Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"107319","DOI":"10.1016\/j.yebeh.2020.107319","article-title":"Cognitive, behavioral, and social functioning in children and adults with Dravet syndrome","volume":"112","author":"Brown","year":"2020","journal-title":"Epilepsy Behav."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1172\/JCI66220","article-title":"Sudden unexpected death in a mouse model of Dravet syndrome","volume":"123","author":"Kalume","year":"2013","journal-title":"J Clin Invest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"107079","DOI":"10.1016\/j.yebeh.2020.107079","article-title":"Intellectual functioning and behavior in Dravet syndrome: a systematic review","volume":"108","author":"Jansson","year":"2020","journal-title":"Epilepsy Behav."},{"key":"B12","doi-asserted-by":"publisher","first-page":"743726","DOI":"10.3389\/fneur.2021.743726","article-title":"SCN1A mutation-beyond Dravet syndrome: a systematic review and narrative synthesis","volume":"12","author":"Ding","year":"2021","journal-title":"Front Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1093\/brain\/awaa274","article-title":"Cortical disinhibition in Parkinson's disease","volume":"143","author":"Ammann","year":"2020","journal-title":"Brain."},{"key":"B14","article-title":"Vagus nerve stimulation and seizure outcomes in pediatric refractory epilepsy: systematic review and meta-analysis","volume-title":"Neurology.","author":"Jain","year":"2021"},{"key":"B15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s13311-017-0537-8","article-title":"Vagal nerve stimulation for treatment-resistant depression","volume":"14","author":"Carreno","year":"2017","journal-title":"Neurotherapeutics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s13311-021-01057-y","article-title":"Network substrates of centromedian nucleus deep brain stimulation in generalized pharmacoresistant epilepsy","volume":"18","author":"Torres Diaz","year":"2021","journal-title":"Neurotherapeutics."},{"key":"B17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/ner.13349","article-title":"Deep brain stimulation for refractory focal epilepsy: unraveling the insertional effect up to five months without stimulation","volume":"24","author":"Thuberg","year":"2021","journal-title":"Neuromodulation."},{"key":"B18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.eplepsyres.2019.02.003","article-title":"Brain-responsive neurostimulation for epilepsy (RNS\u00ae System)","volume":"153","author":"Skarpaas","year":"2019","journal-title":"Epilepsy Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/14737175.2017.1331129","article-title":"Chronic subthreshold cortical stimulation: a therapeutic and potentially restorative therapy for focal epilepsy","volume":"17","author":"Lundstrom","year":"2017","journal-title":"Expert Rev Neurother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.seizure.2020.09.027","article-title":"Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: a critical review","volume":"83","author":"Toffa","year":"2020","journal-title":"Seizure."},{"key":"B21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/0883073816687221","article-title":"Vagus nerve stimulation in intractable epilepsy associated with SCN1A gene abnormalities","volume":"32","author":"Fulton","year":"2017","journal-title":"J Child Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00381-016-3201-4","article-title":"Palliative epilepsy surgery in Dravet syndrome-case series and review of the literature","volume":"32","author":"Dlouhy","year":"2016","journal-title":"Childs Nerv Syst."},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.eplepsyres.2015.02.009","article-title":"Vagus nerve stimulation in children less than 3 years with medically intractable epilepsy","volume":"112","author":"Fernandez","year":"2015","journal-title":"Epilepsy Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eplepsyres.2014.10.014","article-title":"Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen","volume":"109","author":"Dressler","year":"2015","journal-title":"Epilepsy Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1528-1167.2011.03009.x","article-title":"Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet","volume":"52","author":"Caraballo","year":"2011","journal-title":"Epilepsia."},{"key":"B26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejpn.2010.09.003","article-title":"Clinical course of young patients with Dravet syndrome after vagal nerve stimulation","volume":"15","author":"Zamponi","year":"2011","journal-title":"Eur J Paediatr Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000345132","article-title":"Effect of vagus nerve stimulation in an adult patient with Dravet syndrome: contribution to sudden unexpected death in epilepsy risk reduction?","volume":"69","author":"Spatola","year":"2013","journal-title":"Eur Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.seizure.2008.06.010","article-title":"Vagus nerve stimulation in pediatric epileptic syndromes","volume":"18","author":"Rossignol","year":"2009","journal-title":"Seizure."},{"key":"B29","doi-asserted-by":"publisher","first-page":"007","DOI":"10.1055\/s-0035-1567851","article-title":"Vagal nerve stimulation: is it effective in children with Dravet syndrome?","volume":"5","author":"Sirsi","year":"2016","journal-title":"J Pediatr Epilepsy."},{"key":"B30","doi-asserted-by":"crossref","first-page":"036014","DOI":"10.1088\/1741-2552\/ab914f","article-title":"Alteration in brain connectivity in patients with Dravet syndrome after vagus nerve stimulation (VNS): exploration of its effectiveness using graph theory analysis with electroencephalography","volume":"17","author":"Wang","year":"2020","journal-title":"J Neural Eng."},{"key":"B31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-211-35205-2_18","article-title":"Vagus nerve stimulation in pediatric intractable epilepsy: a Korean bicentric study","volume":"99","author":"Kang","year":"2006","journal-title":"Acta Neurochir Suppl."},{"key":"B32","doi-asserted-by":"publisher","first-page":"106665","DOI":"10.1016\/j.eplepsyres.2021.106665","article-title":"Long-term results of vagus nerve stimulation in children with Dravet syndrome: time-dependent, delayed antiepileptic effect","volume":"174","author":"Youn","year":"2021","journal-title":"Epilepsy Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00381-010-1314-8","article-title":"Vagus nerve stimulation: effectiveness and tolerability in patients with epileptic encephalopathies","volume":"27","author":"Cers\u00f3simo","year":"2011","journal-title":"Childs Nerv Syst."},{"key":"B34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pedneo.2012.04.005","article-title":"Short-term results of vagus nerve stimulation in pediatric patients with refractory epilepsy","volume":"53","author":"Chen","year":"2012","journal-title":"Pediatr Neonatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1528-1167.2008.01940.x","article-title":"Vagus nerve stimulation for refractory epilepsy in children: more to VNS than seizure frequency reduction","volume":"50","author":"Shahwan","year":"2009","journal-title":"Epilepsia."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/j.1528-1167.2009.02408.x","article-title":"Dravet syndrome and deep brain stimulation: seizure control after 10 years of treatment","volume":"51","author":"Andrade","year":"2010","journal-title":"Epilepsia."},{"key":"B37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.seizure.2020.07.011","article-title":"Efficacy of the ketogenic diet in patients with Dravet syndrome: a meta-analysis","volume":"81","author":"Wang","year":"2020","journal-title":"Seizure."},{"key":"B38","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s40263-019-00666-8","article-title":"Recent advances in the drug treatment of Dravet syndrome","volume":"33","author":"Wirrell","year":"2019","journal-title":"CNS Drugs."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1111\/j.1528-1167.2011.03107.x","article-title":"Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study","volume":"52","author":"Nabbout","year":"2011","journal-title":"Epilepsia."},{"key":"B40","article-title":"Guidance on Dravet syndrome from infant to adult care: road map for treatment planning in Europe","volume-title":"Epilepsia Open.","author":"Cardenal-Mu\u00f1oz","year":"2021"},{"key":"B41","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1111\/epi.16334","article-title":"Dravet syndrome: treatment options and management of prolonged seizures","volume":"60","author":"Cross","year":"2019","journal-title":"Epilepsia."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1528-1167.2005.05705.x","article-title":"Ketogenic diet in patients with Dravet syndrome","volume":"46","author":"Caraballo","year":"2005","journal-title":"Epilepsia."},{"key":"B43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1056\/NEJMc1512758","article-title":"Cannabinoids in the treatment of epilepsy","volume":"374","author":"Daniel","year":"2016","journal-title":"N Engl J Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.yebeh.2016.11.012","article-title":"Cannabinoids in treatment-resistant epilepsy: a review","volume":"70","author":"O\"Connell","year":"2017","journal-title":"Epilepsy Behav."},{"key":"B45","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.33588\/rn.72S01.2021017","article-title":"New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol","volume":"72","author":"Villanueva","year":"2021","journal-title":"Rev Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2019.03.014","article-title":"Cannabidiol: A review of clinical efficacy and safety in epilepsy","volume":"96","author":"Samanta","year":"2019","journal-title":"Pediatr Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMc1708349","article-title":"Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome","volume":"377","author":"Devinsky","year":"2017","journal-title":"N Engl J Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","article-title":"dose-ranging effect of adjunctive oral cannabidiol vs. placebo on convulsive seizure frequency in Dravet syndrome: a randomized clinical trial","volume":"77","author":"Miller","year":"2020","journal-title":"JAMA Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1111\/epi.17036","article-title":"Add-on cannabidiol in patients with Dravet syndrome: results of a long-term open-label extension trial","volume":"62","author":"Scheffer","year":"2021","journal-title":"Epilepsia."},{"key":"B51","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneurol.2017.86","article-title":"Epilepsy: Cannabidiol reduces seizure frequency in Dravet syndrome","volume":"13","author":"Ridler","year":"2017","journal-title":"Nat Rev Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.seizure.2021.05.014","article-title":"Two-center experience of cannabidiol use in adults with Dravet syndrome","volume":"91","author":"Silvennoinen","year":"2021","journal-title":"Seizure."},{"key":"B53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2017.01.025","article-title":"Optimizing the diagnosis and management of Dravet syndrome: recommendations from a North American consensus panel","volume":"68","author":"Wirrell","year":"2017","journal-title":"Pediatr neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/epi.14628","article-title":"Long-term cannabidiol treatment in patients with Dravet syndrome: an open-label extension trial","volume":"60","author":"Devinsky","year":"2019","journal-title":"Epilepsia."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1111\/epi.16974","article-title":"Time to onset of cannabidiol treatment effects in Dravet syndrome: analysis from two randomized controlled trials","volume":"62","author":"Madan Cohen","year":"2021","journal-title":"Epilepsia."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1111\/j.1528-1167.2009.02179.x","article-title":"Stiripentol open study in Japanese patients with Dravet syndrome","volume":"50","author":"Inoue","year":"2009","journal-title":"Epilepsia."},{"key":"B57","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/jamaneurol.2019.4113","article-title":"Fenfluramine for treatment-resistant seizures in patients with Dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial","volume":"77","author":"Nabbout","year":"2020","journal-title":"JAMA Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/epi.16690","article-title":"et al. Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a real-world study","volume":"61","author":"Specchio","year":"2020","journal-title":"Epilepsia"},{"key":"B59","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s40263-012-0004-3","article-title":"Stiripentol : in severe myoclonic epilepsy of infancy (Dravet syndrome)","volume":"26","author":"Plosker","year":"2012","journal-title":"CNS Drugs."},{"key":"B60","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40263-017-0432-1","article-title":"Stiripentol in the management of epilepsy","volume":"31","author":"Nickels","year":"2017","journal-title":"CNS Drugs."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s40265-019-01204-y","article-title":"Stiripentol: a review in Dravet syndrome","volume":"79","author":"Frampton","year":"2019","journal-title":"Drugs."},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.1111\/epi.16722","article-title":"Fenfluramine HCl (Fintepla) provides long-term clinically meaningful reduction in seizure frequency: analysis of an ongoing open-label extension study","volume-title":"Epilepsia.","author":"Sullivan","year":"2020"},{"key":"B63","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1097\/NRL.0b013e31815c0fbc","article-title":"Surgery and electrical stimulation in epilepsy: selection of candidates and results","volume":"13","author":"Villanueva","year":"2007","journal-title":"Neurologist."},{"key":"B64","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5698\/1535-7597.18.3.170","article-title":"The relation between lesion removal and seizure freedom after epilepsy surgery: all lesions are not created equal","volume":"18","author":"Jehi","year":"2018","journal-title":"Epilepsy Curr."},{"key":"B65","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2017.11.170","article-title":"Parahippocampectomy as a New Surgical Approach to Mesial Temporal Lobe Epilepsy Caused By Hippocampal Sclerosis: A Pilot Randomized Comparative Clinical Trial","volume-title":"World Neurosurg.","author":"Alonso-Vanegas","year":"2018"},{"key":"B66","doi-asserted-by":"publisher","first-page":"16571","DOI":"10.1073\/pnas.1906833116","article-title":"Catterall W. Hippocampal deletion of Na11 channels in mice causes thermal seizures and cognitive deficit characteristic of Dravet Syndrome","volume":"116","author":"Stein","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B67","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.biopsych.2004.09.019","article-title":"The antidepressant properties of the ketogenic diet","volume":"56","author":"Murphy","year":"2004","journal-title":"Biol Psychiatry."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/epi.16543","article-title":"Use of ketogenic diet therapy in infants with epilepsy: a systematic review and meta-analysis","volume":"61","author":"Lyons","year":"2020","journal-title":"Epilepsia."},{"key":"B69","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fneur.2019.00625","article-title":"The efficacy of ketogenic diet in 60 Chinese patients with Dravet syndrome","volume":"10","author":"Tian","year":"2019","journal-title":"Front Neurol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"106671","DOI":"10.1016\/j.eplepsyres.2021.106671","article-title":"Is vagal-nerve stimulation safe during pregnancy?","volume":"174","author":"Ding","year":"2021","journal-title":"A mini review Epilepsy Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fnins.2020.00284","article-title":"Critical review of transcutaneous vagus nerve stimulation: challenges for translation to clinical practice","volume":"14","author":"Yap","year":"2020","journal-title":"Front Neurosci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1468-2982.2005.00611.x","article-title":"Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches","volume":"25","author":"Mauskop","year":"2005","journal-title":"Cephalalgia."},{"key":"B73","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.neubiorev.2020.03.034","article-title":"Vagus nerve stimulation and neurotrophins: a biological psychiatric perspective","volume":"113","author":"Rosso","year":"2020","journal-title":"Neurosci Biobehav Rev."},{"key":"B74","doi-asserted-by":"publisher","first-page":"273","DOI":"10.20882\/adicciones.120","article-title":"New neurostimulation techniques in adicctions","volume":"23","author":"Garc\u00eda-Toro","year":"2011","journal-title":"Adicciones."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.brs.2020.06.078","article-title":"Differential effects of vagus nerve stimulation paradigms guide clinical development for Parkinson's disease","volume":"13","author":"Farrand","year":"2020","journal-title":"Brain Stimul."},{"key":"B76","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/03009742.2020.1764617","article-title":"Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study","volume":"50","author":"Drewes","year":"2021","journal-title":"Scand J Rheumatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/nmo.12076","article-title":"Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway","volume":"25","author":"Bonaz","year":"2013","journal-title":"Neurogastroenterol Motil."},{"key":"B78","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1553-2712.2012.01329.x","article-title":"Feasibility of percutaneous vagus nerve stimulation for the treatment of acute asthma exacerbations","volume":"19","author":"Miner","year":"2012","journal-title":"Acad Emerg Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nec.2018.12.005","article-title":"Vagus nerve stimulation for the treatment of epilepsy","volume":"30","author":"Gonz\u00e1lez","year":"2019","journal-title":"Neurosurg Clin N Am."},{"key":"B80","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/epi.16851","article-title":"The role of surgery in the management of Lennox-Gastaut syndrome: a systematic review and meta-analysis of the clinical evidence","volume":"62","author":"Thirunavu","year":"2021","journal-title":"Epilepsia."},{"key":"B81","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.seizure.2017.06.007","article-title":"Efficacy of adjunctive vagus nerve stimulation in patients with Dravet syndrome: a meta-analysis of 68 patients","volume":"50","author":"Dibu\u00e9-Adjei","year":"2017","journal-title":"Seizure."},{"key":"B82","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/epi.13964","article-title":"Deep brain stimulation for drug-resistant epilepsy","volume":"59","author":"Li","year":"2018","journal-title":"Epilepsia."},{"key":"B83","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2018.4.FOCUS1872","article-title":"Deep brain stimulation for seizure control in drug-resistant epilepsy","volume":"45","author":"Klinger","year":"2018","journal-title":"Neurosurg Focus."},{"key":"B84","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(20)30323-9","article-title":"Studies of deep brain stimulation in Parkinson's disease","volume":"19","author":"Vitek","year":"2020","journal-title":"Lancet Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.843975\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T14:18:10Z","timestamp":1649859490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.843975\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":84,"alternative-id":["10.3389\/fneur.2022.843975"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.843975","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"article-number":"843975"}}